Martin Sanders has had a long career in biomedical basic research, biopharmaceutical product development, executive management of life science companies, and venture capital investing in early stage life science companies.  He also serves as a founding member of the advisory board for the University of Chicago Polsky Center Innovation Fund.


Dr. Sanders is a graduate of the University of Chicago Pritzker School of Medicine. He completed post-graduate training in Internal Medicine at Washington University School of Medicine, post-doctoral training in Allergy and Clinical Immunology at the National Institute of Health, and in Rheumatology at the Johns Hopkins School of Medicine. He is board certified in Internal Medicine, Allergy and Clinical Immunology, and Rheumatology. 




CEO and President

Yuan Zhang is the co-founder of Seurat Therapeutics and a former Associate in the Polsky Innovation Fund at the University of Chicago. There, she evaluated promising startups to help the Innovation Fund Advisors make investment decisions about various research discoveries that can turn into impactful ventures. With a biomedical science background, Dr. Zhang is passionate about translating basic research into healthcare solutions.


Dr. Zhang received her undergraduate degree in Biological Sciences, and a dual Master’s degree in Translational Sciences and a Ph.D. in Molecular Pathogenesis and Molecular Medicine from the University of Chicago. Her Master’s program was supported by the Howard Hughes Medical Institute, aiming to develop basic science researchers with a translational medicine focus. Dr. Zhang was also a postdoctoral scholar in Dr. Ralph Weichselbaum’s lab in the Department of Radiation and Cellular Oncology at UChicago Medicine.




Chief Scientific Officer

Richard Kraig is a board-certified neurologist and leads the Migraine Headache clinic at the University of Chicago. Dr. Kraig’s research centers on developing novel neurotherapeutics based on deciphering the immune signaling by which environmental enrichment (i.e., increased creativity and physical activity) improves brain health.


Dr. Kraig is also a professor in the Department of Neurology at The University of Chicago and the William D. Mabie Professor in the Neurosciences. He received his B.A. in Chemistry from Cornell College, his Ph.D. in Physiology and Biophysics from the University of Iowa, his M.D. from New York University, and completed his internship in Medicine at the University of Chicago as well as his residency in Neurology at the New York Hospital-Cornell Medical College.



Chief Financial Officer

Sharon Lew has over 21 years of experience in business development, sales, marketing, and operations in global companies and early stage startups. These companies include Toshiba, ADAC Labs, Polymer Technology Group, DecisionView, Pano Logic, Ephox Corporation, Quantum 3D, Inc. and Jasmine Networks, Inc.


Ms. Lew’s has worked in multiple healthcare-related fields including nuclear medicine imaging equipment, radiation therapy planning systems, positron emission tomography, computerized tomography, and magnetic resonance imaging systems, clinical trials performance optimization software, and biomedical devices. She holds a M.S. in Marketing from Golden Gate University and a B.S. in Business Administration from San Francisco State University.


Scott Meadow, MBA

Board Member

Scott Meadow is a private equity professional and faculty member of the University of Chicago Booth School of Business, where he is a clinical professor of entrepreneurship. He is the recipient of the Richard J. Daley Award. The Daley Medal acknowledges a single individual who has given direct and extraordinary support to the state of Illinois by participating in or being an advocate for the venture capital and private equity industry.

For nearly thirty years, Meadow has been a principal investor in the venture capital and private equity industry. He started his career at William Blair and Company, where he became a partner in 1983. He has been a General Partner at William Blair Venture Partners, Frontenac Company, the Sprout Group and is an associate partner at Edgewater Growth Capital Partners and founder of Maroon Partners, a consultancy enterprise focused on advising entrepreneurial and private equity endeavors and providing expert witness support in commercial disputes.

Throughout his career, he has approved hundreds of equity financings, and originated or created more than sixty investments including two dozen healthcare service companies.

Copyright © 2017 Seurat Therapeutics Inc. All rights reserved.